Neuralynx, Inc.

FHC, Inc. is a specialized medical device manufacturer based in Bowdoin, Maine, founded in 1970. The company focuses on neuroscience and neurosurgery solutions, particularly cranial microtargeting and neuromodulation. FHC designs and manufactures microelectrodes, electrode positioning systems, stereotactic platforms, and surgical planning software for both clinical and research applications. Their clinical product line includes the Guideline 5 Neuromodulation System, STarFix Stereotactic Platforms, STar Microdrive System, and WayPoint Navigation software for surgical planning. The research division offers NeuroCraft microelectrodes and insertion tubes for neurophysiology studies. FHC's solutions support therapeutic interventions including deep brain stimulation, ablation, resection, and treatment of movement disorders such as Parkinson's Disease, epilepsy, dystonia, and essential tremor. The company also provides stereoelectroencephalography (SEEG) equipment and operates Greenville Neuromodulation Services for DBS research and surgeon training. With approximately 170 employees and estimated annual revenue of $42.6 million, FHC serves neurosurgical centers and research institutions globally.